Skip to content
Screener

McKesson MCK Non-Controlling Interests

Non-Controlling Interests at other companies

Cencora logo
CencoraCOR
$188.13M
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$0+100%
Medline, Inc. logo
Medline, Inc.MDLN
$7.51B
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$63K+150%
CVS Health logo
CVS HealthCVS
$197M
Baxter International logo
Baxter InternationalBAX
-$27M0.0%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$102.7B+16.8%
Enterprise value$110.42B+14.5%
P/E22.4×-5.4×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
Line itemJune 30, 2026March 31, 2026
Additional paid-in capital8,5888,284
Retained earnings22,80822,291
Accumulated other comprehensive loss(749)(745)
Treasury shares, at cost, 164 and 160 shares at June 30, 2026 and March 31, 2026, respectively(34,890)(32,005)
Total McKesson Corporation stockholders’ deficit(4,240)(2,172)
Noncontrolling interests376395
Total deficit(3,864)(1,777)
Total liabilities, redeemable noncontrolling interests, and deficit$88,330$82,323

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's non-controlling interests?
McKesson (MCK) reported non-controlling interests of $376M in Q2 2026.
How has McKesson's non-controlling interests changed year-over-year?
McKesson's non-controlling interests decreased by 0.8% year-over-year, from $379M to $376M.
What is the long-term trend for McKesson's non-controlling interests?
Over 5 years (2021 to 2026), McKesson's non-controlling interests has grown at a 15.0% compound annual growth rate (CAGR), from $196M to $395M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.

Ask your AI about McKesson's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude